AN OPEN-LABEL TRIAL OF THE PPAR-g LIGAND PIOGLITAZONE FOR IDIOPATHIC GASTROPARESIS: A FIRST STEP TOWARDS DISEASE MODIFYING THERAPY
GASTROENTEROLOGY(2022)
关键词
idiopathic gastroparesis,open-label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
GASTROENTEROLOGY(2022)